Interestingly, loss of Mst1/2 or Mst1/2 kinases inhibitor treatment abrogated filopodia formation or actin accumulation at sites of bacteria induced by LPS or the Piezo1 agonist Yoda1 treatment or E. coli infection (Fig. 5a, b). The gene discussed is PIEZO1; the disease is escherichia coli infection.